|
|
||||||||
1 Antibody Research Laboratories, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., Tokyo 194-8533, Japan
2 Department of Reproductive Medicine, University of California San Diego School of Medicine, La Jolla, California 92093-0633, USA
(RECEIVED September 6, 2007; FINAL REVISION November 2, 2007; ACCEPTED November 12, 2007)
Bone morphogenetic protein-15 (BMP-15) is an oocyte-secreted factor critical for the regulation of ovarian physiology. When recombinant human BMP-15 (rhBMP-15) produced in human embryonic kidney 293 cells was subjected to SDS-PAGE analysis, two mature protein forms corresponding to 16 kDa (P16) and 17 kDa (P17) were observed. Despite the physiological relevance and critical function of BMP-15 in female reproduction, little is known about the structure of rhBMP-15. Here, we have analyzed the structure of the rhBMP-15 mature proteins (P16 and P17) using state-of-the-art proteomics technology. Our findings are as follows: (1) the N-terminal amino acid of P16 and P17 is pyroglutamic acid; (2) the Ser residue at the sixth position of P16 is phosphorylated; (3) P17 is O-glycosylated at Thr10; and (4) the C-terminal amino acid of P16 and P17 is truncated. These findings are the first knowledge of the structure of rhBMP-15 mature protein toward understanding the molecular basis of BMP-15 function and could provide an important contribution to the rapidly progressing research area involving oocyte-specific growth factors in modulation of female fertility.
Keywords: bone morphogenetic protein; post-translational modification; mass spectrometry; phosphorylation; neutral loss scan; O-glycosylation; proteomics analysis; pyroglutamic acid
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |